These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32148354)

  • 1. Successfully Treated Hepatitis B Positive Refractory Myasthenic Crisis with Rituximab.
    Singh RK; Joshi D; Rath S
    Indian J Crit Care Med; 2020 Jan; 24(1):71-72. PubMed ID: 32148354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence and severity of myasthenic crisis in an unselected Turkish cohort of patients with myasthenia gravis.
    Ozyurt Kose S; Nazli E; Tutkavul K; Gilhus NE
    Front Neurol; 2023; 14():1201451. PubMed ID: 37521306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab in the Management of Refractory Myasthenia Gravis and Variability of Its Efficacy in Anti-MuSK Positive and Anti-AChR Positive Myasthenia Gravis.
    Bastakoti S; Kunwar S; Poudel S; Quinonez J; Bista S; Singh N; Jha V; Ruxmohan S; Paesani S; Cueva W; Michel J
    Cureus; 2021 Nov; 13(11):e19416. PubMed ID: 34909332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed Diagnosis of Atypical Presentation of Myasthenia Gravis.
    Mustafa MS; Marshal M; Ahern E; Crowley P
    Eur J Case Rep Intern Med; 2018; 5(2):000785. PubMed ID: 30756011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy-induced myasthenic crisis in thymoma treated with primary chemotherapy with curative intent on mechanical ventilation: a case report and review of the literature.
    Patelli G; Bencardino K; Tosi F; Pugliano M; Lanzani F; Innocenti A; Rinaldo A; Mauri G; Cerea G; Sartore-Bianchi A; Torre M; Agostoni EC; Siena S
    J Med Case Rep; 2021 Feb; 15(1):32. PubMed ID: 33526108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myasthenia Gravis and Congenital Myasthenic Syndromes.
    Ciafaloni E
    Continuum (Minneap Minn); 2019 Dec; 25(6):1767-1784. PubMed ID: 31794470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenia gravis: management of myasthenic crisis and perioperative care.
    Juel VC
    Semin Neurol; 2004 Mar; 24(1):75-81. PubMed ID: 15229794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of myasthenic crisis in a child.
    Rybojad B; Lesiuk W; Fijałkowska A; Rybojad P; Sawicki M; Lesiuk L
    Anaesthesiol Intensive Ther; 2013; 45(2):82-4. PubMed ID: 23877900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myasthenia gravis exacerbation and myasthenic crisis associated with COVID-19: case series and literature review.
    Rodrigues CL; de Freitas HC; Lima PRO; de Oliveira Junior PH; Fernandes JMA; D'Almeida JAC; Nóbrega PR
    Neurol Sci; 2022 Apr; 43(4):2271-2276. PubMed ID: 35039987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lady With the Blue Hair: An Atypical Cause of Myasthenic Crisis.
    Gomez Rosado JO; Perez T; Fusco KN; Ahmed F; Nelson TL; Smith TA; Ma H; Barber T
    Cureus; 2024 May; 16(5):e60186. PubMed ID: 38868287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rescue treatment with add-on efgartigimod in a patient with impending myasthenic crisis: a case report.
    Zhang Z; Yang M; Luo T; Du X; Wang Z; Huang X; Zhang Y
    Ther Adv Neurol Disord; 2024; 17():17562864241254895. PubMed ID: 38813520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efgartigimod as Rescue Medication in a Patient with Therapy-Refractory Myasthenic Crisis.
    Alhaj Omar O; Diel NJ; Gerner ST; Mück A; Huttner HB; Krämer-Best HH
    Case Rep Neurol Med; 2024; 2024():9455237. PubMed ID: 38939234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Analysis of Intravenous Immunoglobulins (IVIg) vs Plasmapheresis (PLEX) in the Management of Myasthenic Crisis.
    Zain A; Akram MS; Ashfaq F; Ans A; Ans HH
    Cureus; 2024 Sep; 16(9):e68895. PubMed ID: 39376877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective Early Treatment of AChR Antibody-Positive Myasthenia Gravis with Rituximab; the Experience from a Neuroimmunology Clinic in a Developing Country.
    Mathew T; Thomas K; K John S; Venkatesh S; Nadig R; Badachi S; Souza DD; Sarma G; Parry GJ
    J Cent Nerv Syst Dis; 2021; 13():11795735211016080. PubMed ID: 34045914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the burden of refractory myasthenia gravis.
    Schneider-Gold C; Hagenacker T; Melzer N; Ruck T
    Ther Adv Neurol Disord; 2019; 12():1756286419832242. PubMed ID: 30854027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myasthenic Crisis.
    Kirmani JF; Yahia AM; Qureshi AI
    Curr Treat Options Neurol; 2004 Jan; 6(1):3-15. PubMed ID: 14664765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenia gravis masquerading as dysphagia: unveiled by magnesium infusion.
    Klair JS; Rochlani YM; Meena NK
    BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24744075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of myasthenia gravis which developed myasthenic crisis after alpha-interferon therapy for chronic hepatitis C].
    Konishi T
    Rinsho Shinkeigaku; 1996 Aug; 36(8):980-5. PubMed ID: 8958752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case report: Recovery from refractory myasthenic crisis to minimal symptom expression after add-on treatment with efgartigimod.
    Watanabe K; Ohashi S; Watanabe T; Kakinuma Y; Kinno R
    Front Neurol; 2024; 15():1321058. PubMed ID: 38318438
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.